Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06711380 · ClinicalTrials.gov registry record · NA
Patient Ambassador
A NA study, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT06711380 is a NA study that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 23 participants.
The verdict
NCT06711380, a NA study, has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
The overall objective of this study is to design and evaluate a peer ambassador intervention to improve gynecologic cancer trial enrollment. The primary Aim is to determine the possibility of using peer ambassadors to increase discussion, awareness, and enrollment of patients with advanced or recurrent gynecologic cancer onto clinical trials.
Interventions
- OTHER Peer Ambassador
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2024-02-09 |
| Est. Completion | 2025-10-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06711380
The ClinicalTrials.gov registry entry for NCT06711380 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Peer Ambassador is the first listed.
NCT06711380 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06711380 about?
NCT06711380 is a clinical study titled "Patient Ambassador". The overall objective of this study is to design and evaluate a peer ambassador intervention to improve gynecologic cancer trial enrollment. The primary Aim is to determine the possibility of using peer ambassadors to increase discussion, awareness, and enrollment of patients with advanced or recurr...
What is the current status of trial NCT06711380?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2024-02-09. Estimated completion is 2025-10-31.
What interventions are being tested in trial NCT06711380?
The interventions under investigation include: Peer Ambassador (OTHER).
Who is sponsoring clinical trial NCT06711380?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.